Publication | Open Access

Design, synthesis and evaluation of nitric oxide releasing derivatives of 2,4-diaminopyrimidine as novel FAK inhibitors for intervention of metastatic triple-negative breast cancer

Medicinal ChemistryBreast OncologyNovel Fak InhibitorsMedicinePharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyDrug Discovery